Newton Latondra reported grant involving 17 shares of PHINIA INC. at $0.00 for $0 on Sep 18, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Sep 21, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
17Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
19,953Direct
Trade date
Sep 18, 2026Grant
Filed
Sep 21, 2026, 5:50 PM ET3-day reporting delay
Accession
0001968915-26-000146Code A · Transaction 226992
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 18, 2026Grant10$0.00$0Trade 226993
2 transaction rows in this filing. Joint filers share the same rows.

PHIN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PHIN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +21%1w ago +9.8%1d ago +2.8%
Returns since7d +0.7%30d −5.3%90d180d1y

Footnotes in full

F1: Represents shares of deferred restricted stock units ("DRSUs") acquired following the automatic reinvestment of dividends on outstanding DRSUs held on the dividend record date, as required by the terms of such awards. F2: Includes 3,397 DRSUs that have vested and will settle upon the reporting person's termination of board service. F3: Each DRSU is the economic equivalent of one share of PHINIA Inc. common stock and will vest on May 22, 2027. These DRSUs will settle into an equal number of shares of the issuer's common stock, including any additional DRSUs acquired as a result of dividend equivalents that have vested, upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan.